Margaret Hamburg Announces She Will Step Down in March 2015
Margaret Hamburg announced on Feb. 5, 2015 that she will step down as FDA Commissioner after serving in the position for almost six years.

Advertisement: The 2015 PDA Annual Meeting offers the most concentrated education and networking opportunities with leading industry experts focused on Bio/Pharmaceutical science, manufacturing technology, quality and evolving regulations. It will provide a look into the future of manufacturing and the actions necessary today to prepare for the changes of tomorrow. Extend your learning with the post-conference Aging Facilities Workshop and Course Series.

Pfizer to Acquire Hospira for Nearly $17 Billion
The deal may offset billions of dollars in waning sales from Pfizer drugs slated to lose patent protection and provide Pfizer with a whole portfolio of biosimilar products.

Thermo Fisher Scientific Acquires Advanced Scientifics
Thermo Fisher Scientific adds Advanced Scientific’s custom single-use systems and equipment to its bioprocessing offerings.

Mylan Partners with Theravance to Develop an Investigational Treatment for COPD
Mylan announced a partnership with Theravance Biopharma to develop and commercialize TD-4208, a novel investigational COPD treatment.

FDA Approves HIV Treatments from BMS and J&J
Bristol-Myers Squibb and Johnson & Johnson announced FDA-approval of Evotaz and Prezcobix, combination HIV-1 infection treatments.

First Inhalable Insulin Comes to the US
Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.

FDA Accelerates Approval to Pfizer's Palbociclib
The cyclin-dependent kinase 4/6 inhibitor for the treatment of metastatic breast cancer was approved more than two months ahead of the prescription drug user fee goal date.

Obama Budget Blueprint Seeks Drug Pricing Authority, Shortened Data Exclusivity Period for Biologics
The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.

Advertisement: Developing a Comprehensive Tool Kit for Microbial Identification On Demand Click here to Register free.

Aesica Announces FDA Approvals for Germany Facility
Aesica announced that it received continuing approvals from FDA for its bulk manufacturing and packaging operations in Germany.

Precision Biologics Enlists the Help of EMD Millipore for Upstream Process Development
EMD Millipore will provide process development services for Precision Biologics’ preclinical monoclonal antibody.

Advertisement: Enhancing Quality and Process Efficiency using Continuous Manufacturing Technology for Drug Substance and Drug Product On Demand Click here to Register free.

Shantha Constructs Insulin Facility in India
The Shantha facility will be Sanofi's second, in addition to its site in Frankfurt, for production of Insuman insulin.

Regis Reveals New Potent Compound Capabilities at InformEx 2015
Regis Technologies announced it will unveil its new potent compound capabilities at InformEx 2015, Feb. 3–5.

Advertisement: Pharma Supply Chain Security: Are You in Control? Live webcast: February 25, 2015 at 11AM ET In this program, an expert shares best practices that will prevent liability and noncompliance, improve quality and boost supply chain efficiency. Register free www.pharmtech.com/security

Quality is Key
CPhI experts make predictions on pharma trends for 2015.

AstraZeneca Partners with MD Anderson on Cancer Therapy Development
AstraZeneca and the University of Texas MD Anderson Cancer Center announced a plan to collaborate for the improvement of patient outcomes in clinical trials with investigational therapies.

Recipharm Completes China-Focused Serialization Project
Recipharm has completed a serialization project for China on behalf of one of its customers.

Vetter Expands Ravensburg Site
Structural work was completed for the new building, which will contain laboratory space for performing microbiological analysis as well as a data center.